BLK
BlackRock, Inc.
BLK's fundamentals are mixed, but it looks expensive: trading at 28x earnings, above its usual 22x.
MRX
Marex Group plc Ordinary Shares
There isn't enough reported data to score MRX yet.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
MRX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| N/A | |
| N/A |
There isn't enough reported data to rate MRX's fundamentals.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
MRX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | N/A | N/A |
| Fair | 14x | N/A | N/A |
| Expensive | 17x | N/A | N/A |
| Current | 18x | $71.68 | — |
Historical ranges are pointers, not guarantees.
MRX's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
MRX Forward outlook
There aren't enough analyst estimates for MRX to show an outlook.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK earned $43.87 per share over the past year, up 11% from the year before.
MRX Earnings Per Share
MRX and BLK do not have enough comparable growth data to identify a winner.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK's revenue has grown year over year for 13 quarters in a row: $7.8B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK's operating margin was 30% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
MRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2B | +306% |
| Q4 2025 | $3.1B | +45% |
| Q2 2025 | $500.1M | -32% |
| Q4 2024 | $2.2B | +199% |
| Q2 2024 | $740M | -36% |
| Q4 2023 | $720.7M | +109% |
| Q2 2023 | $1.2B | +75% |
| Q4 2022 | $345.3M | -16% |
MRX has the edge over BLK in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 59% | +6.1 points |
| Q4 2025 | 34% | +50 points |
| Q2 2025 | 20% | +19 points |
| Q4 2024 | 20% | +2.2 points |
| Q2 2024 | 53% | +47 points |
| Q4 2023 | -16% | -25 points |
| Q2 2023 | 0.8% | -7.5 points |
| Q4 2022 | 18% | +13 points |
MRX has the edge over BLK on profitability, with a higher operating margin.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK's free cash flow was $4.8B over the past year, up 22% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BLK.
MRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $692M | -25% |
| Q4 2025 | -$264.5M | -138% |
| Q2 2025 | $918.9M | +107% |
| Q4 2024 | $704.6M | +95% |
| Q2 2024 | $443.3M | +23% |
| Q4 2023 | $361.5M | +234% |
| Q2 2023 | $361.5M | +234% |
| Q4 2022 | $108.1M | -53% |
MRX's free cash flow was $2.1B over the past year, up 61% from the year before. Free cash flow isn't a meaningful measure for financial services companies like MRX.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has the edge over MRX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
MRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -487K shares |
| 1 year | +4.7% | +3.4M shares |
| 3 years | +25% | +15M shares |
MRX has 76M diluted shares, up 4.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $125.6M |
| Q4 2025 | $200,000 |
| Q2 2025 | — |
| Q4 2024 | — |
| Q2 2024 | $19.8M |
| Q4 2023 | $1.6M |
| Q2 2023 | $1.6M |
| Q4 2022 | $4M |
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
MRX Net Leverage
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
MRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.8 | Neutral |
| Stochastic | 40.9 | Neutral |
MRX's weekly RSI is 59 (neutral) and its Stochastic is 41 (neutral).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
MRX PE vs Financial Services Sector
| Metric | MRX | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 42% above |
| PE % | 93 | 29 | 64 pts above |
MRX has the edge over BLK on valuation relative to its sector.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
MRX has stronger trend alignment. BLK is above 5 of 5 weekly averages versus MRX above 4 of 4.
MRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $69.8 | 2.6% above |
| 20 week MA | $69.1 | 3.8% above |
| 50 week MA | $55.3 | 30% above |
| 100 week MA | $45.7 | 57% above |
MRX is in an uptrend: it's above all four of its weekly moving averages, and 57% above its 100-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has finished higher in five of the last six years. It's up 12% so far in 2026.
MRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.0 | $31.9 | +68% |
| 2025 | $31.9 | $39.6 | +24% |
| 2026 YTD | $39.6 | $71.7 | +81% |
MRX has the edge over BLK on returns for 2026, with the stronger performance.